The final list for new high volume sell-offs was a lot shorter than I thought. However, I would note that the initial screen did expand, which you would expect considering market got hit by more than 1%. That said, there does appear to be a lot of large and well know names that are selling off on high volume. The only reason they are not making the list is that they are already off the highs. I am noticing a number of healthcare related name hitting today's and recent screens.
Biomarin Pharma
CIT Group- CIT
Flaherty & Crumrine Claymore Preferred Securities
First Trust Mortgage Income Fund- FMY
H&Q Healthcare Investors- HQH
Healthstream- HSTM
Nuveen Multi-Strategy Income & Growth Fund- JQC
Regions Financial- RF
Sigma Aldrich- SIAL
Transdigm Group- TDG
Biomarin Pharma
CIT Group- CIT
Flaherty & Crumrine Claymore Preferred Securities
First Trust Mortgage Income Fund- FMY
H&Q Healthcare Investors- HQH
Healthstream- HSTM
Nuveen Multi-Strategy Income & Growth Fund- JQC
Regions Financial- RF
Sigma Aldrich- SIAL
Transdigm Group- TDG
No comments:
Post a Comment